Alessandra Piersigilli

Title: Innovations by Alessandra Piersigilli

Introduction

Alessandra Piersigilli is an accomplished inventor based in Cambridge, MA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions targeting BCMA (B-cell maturation antigen). Her work is pivotal in advancing cancer treatment methodologies.

Latest Patents

Alessandra holds a patent for "Compositions targeting BCMA and methods of use thereof." This invention relates to BCMA binders, such as antibodies, and chimeric antigen receptor (CAR) constructs that include a BCMA antigen binding molecule. The BCMA binders are designed to specifically bind to BCMA, enhancing the efficacy of NK (natural killer) cells in targeting and killing cancer cells. The patent outlines therapeutic uses of these BCMA binders and CARs, showcasing her innovative approach to cancer therapy.

Career Highlights

Alessandra is currently associated with Takeda Pharmaceutical Company Limited, where she continues to push the boundaries of medical research and innovation. Her work is characterized by a commitment to improving patient outcomes through advanced therapeutic strategies.

Collaborations

Alessandra collaborates with notable colleagues, including Michael David Curley and Ertan Eryilmaz. These partnerships enhance her research efforts and contribute to the development of groundbreaking therapies.

Conclusion

Alessandra Piersigilli's contributions to biotechnology and cancer treatment exemplify the impact of innovative thinking in medicine. Her patent on BCMA-targeting compositions represents a significant advancement in therapeutic options for cancer patients.